Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer metabolism

Stress granules shape metabolic reprogramming and drug resistance

Cancer cells form stress granules that enable them to adapt to stress and survive. Research now shows that after drug treatment, hepatocellular carcinoma cells display phase separation mediated by the RIOK1 kinase, which promotes sequestration of PTEN mRNA in stress granules. This activates the pentose phosphate pathway, favoring cell survival.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Formation of stress granules for metabolic reprogramming and stress adaptation in cancer.

References

  1. Yang, C. et al. Nat. Rev. Gastroenterol. Hepatol. 20, 203–222 (2023).

    Article  PubMed  Google Scholar 

  2. Meng, X. et al. Nat. Cancer https://doi.org/10.1038/s43018-025-00984-5 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Redding, A. & Grabocka, E. Trends Cancer 9, 995–1005 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. TeSlaa, T., Ralser, M., Fan, J. & Rabinowitz, J. D. Nat. Metab. 5, 1275–1289 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Stohr, N. et al. J. Cell Biol. 175, 527–534 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Khong, A. et al. Mol. Cell 68, 808–820.e805 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Amen, T. & Kaganovich, D. Cell Rep. 35, 109237 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fournier, M. J., Gareau, C. & Mazroui, R. Cancer Cell Int. 10, 12 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Oaks, Z. et al. Nat. Metab. 5, 41–60 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Li, M. et al. Nat. Cancer 1, 735–747 (2020).

    Article  CAS  PubMed  Google Scholar 

  11. Grabocka, E. & Bar-Sagi, D. Cell 167, 1803–1813.e1812 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Sauer, M. et al. Nat. Commun. 10, 2421 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hu, S. et al. Nat. Commun. 14, 7782 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Plassmeyer, S. P. & Holehouse, A. S. Nature 623, 919–920 (2023).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huiyong Yin.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhong, S., Yin, H. Stress granules shape metabolic reprogramming and drug resistance. Nat Cancer 6, 1129–1130 (2025). https://doi.org/10.1038/s43018-024-00886-y

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43018-024-00886-y

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer